全文获取类型
收费全文 | 853篇 |
免费 | 47篇 |
国内免费 | 3篇 |
专业分类
耳鼻咽喉 | 1篇 |
儿科学 | 17篇 |
妇产科学 | 6篇 |
基础医学 | 147篇 |
口腔科学 | 1篇 |
临床医学 | 60篇 |
内科学 | 168篇 |
皮肤病学 | 2篇 |
神经病学 | 12篇 |
特种医学 | 2篇 |
外科学 | 10篇 |
综合类 | 26篇 |
预防医学 | 406篇 |
眼科学 | 2篇 |
药学 | 30篇 |
中国医学 | 1篇 |
肿瘤学 | 12篇 |
出版年
2024年 | 1篇 |
2023年 | 56篇 |
2022年 | 32篇 |
2021年 | 39篇 |
2020年 | 102篇 |
2019年 | 51篇 |
2018年 | 109篇 |
2017年 | 48篇 |
2016年 | 56篇 |
2015年 | 50篇 |
2014年 | 90篇 |
2013年 | 30篇 |
2012年 | 40篇 |
2011年 | 21篇 |
2010年 | 41篇 |
2009年 | 34篇 |
2008年 | 9篇 |
2007年 | 14篇 |
2006年 | 3篇 |
2005年 | 5篇 |
2004年 | 6篇 |
2003年 | 14篇 |
2002年 | 5篇 |
2001年 | 6篇 |
2000年 | 8篇 |
1999年 | 5篇 |
1998年 | 7篇 |
1997年 | 6篇 |
1996年 | 11篇 |
1995年 | 2篇 |
1994年 | 1篇 |
1993年 | 1篇 |
排序方式: 共有903条查询结果,搜索用时 984 毫秒
1.
2.
《Vaccine》2020,38(51):8185-8193
BackgroundWhile administration of the measles-mumps-rubella (MMR-II®) vaccine has been effective at preventing rubella infection in the United States, the durability of humoral immunity to the rubella component of MMR vaccine has not been widely studied among older adolescents and adults.MethodsIn this longitudinal study, we sought to assess the durability of rubella virus (RV)-specific humoral immunity in a healthy population (n = 98) of adolescents and young adults at two timepoints: ~7 and ~17 years after two doses of MMR-II® vaccination. Levels of circulating antibodies specific to RV were measured by ELISA and an immune-colorimetric neutralization assay. RV-specific memory B cell responses were also measured by ELISpot.ResultsRubella-specific IgG antibody titers, neutralizing antibody titers, and memory B cell responses declined with increasing time since vaccination; however, these decreases were relatively moderate. Memory B cell responses exhibited a greater decline in men compared to women.ConclusionsCollectively, rubella-specific humoral immunity declines following vaccination, although subjects’ antibody titers remain well above the currently recognized threshold for protective immunity. Clinical correlates of protection based on neutralizing antibody titer and memory B cell ELISpot response should be defined. 相似文献
3.
《Vaccine》2020,38(32):4940-4943
To determine the duration of immunity provided by the Hepatitis A vaccination (HepA), we evaluated a cohort of participants in Alaska 20 years after being immunized as infants. At recruitment, participants received two doses of inactivated HepA vaccine on one of three schedules. We conducted hepatitis A antibody (anti-HAV) testing for participants at the 20-year time-point. Seventy-five of the original 183 participants (41%) were available for follow-up. The overall anti-HAV geometric mean concentration was 29.9 mIU/mL (95% CI 22.4 mIU/mL, 39.7 mIU/mL) and 50 participants (68%) remained seropositive (titer ≥ 20 mIU/mL). Using a fractional polynomial model, the predicted percent seropositive at 25 years was 55.3%, 49.8% at 30 years and 45.7% at 35 years, suggesting that the percent sero-positive could drop below 50% earlier than previously expected. Further research is necessary to understand if protection continues after seropositivity diminishes or if a HepA booster dose may become necessary. 相似文献
4.
Shobha Narahari Abida Juwle Subhankar Basak Dhananjaya Saranath 《Infection, genetics and evolution》2009,9(4):643-645
Viral hepatitis represents a major global health problem with 170 million Hepatitis C Virus (HCV) carriers worldwide, and 12–13 million HCV carriers in India. HCV genotypes are of clinical significance in indicating drug responsiveness and prognosis of the patient. The HCV genotypes are of epidemiologic significance as well, as they are indicative of transmission route of infection and have not been extensively studied in the Indian context. In the current study, HCV genotyping was examined in 2118 patients from different geographic regions of India. HCV was detected by PCR amplification of 5′ UTR and core-envelope1 regions, followed by genotyping using nucleotide sequencing and analysis with NCBI tool (http://www.ncbi.nlm.nih.gov/projects/genotyping/formpage.cgi). HCV genotype distribution in the 2118 Indian patients demonstrated prevalence of HCV3 (3a/3b primarily) in 62% and HCV1 (1a/1b primarily) in 31% patients. The predominance of HCV3 was significant in northern (p = 0.01) and eastern (p = 0.008) regions of India. HCV types 2, 4, 5, and 6 were detected in 0.05–4.5% of the patient group. Thus, our studies demonstrate HCV genotype prevalence in the cohort group in different regions of India. 相似文献
5.
目的 分析在新型冠状病毒肺炎流行背景下,2016年4月—2022年3月国内深圳市和济南市流感流行特点,了解我国南北方地区流感流行差异。 方法 使用深圳市和济南市国家级哨点医院2016—2022监测年度流感样病例(ILI)和流感病原学监测资料,分析流感流行特征和趋势。 结果 2016—2022监测年度深圳市和济南市国家级哨点医院的门急诊病例中流感样病例百分比(ILI%)分别为2.25%、3.45%。两地区ILI%最高的年份均为2021—2022监测年度。ILl年龄构成均以0~4岁为主(分别占40%、46%)。按月分析两地区流感病毒分离阳性率与ILI%变化的相关性,两者趋势均存在正相关(r=0.238,P<0.05;r=0.425,P<0.001)。两地区不同监测年度流感优势毒株型别均不相同,呈交替变化,但每年流行的型别及高峰期的优势毒株型别基本一致。 结论 2020—2021监测年度即新型冠状病毒肺炎流行初期,深圳市和济南市流感活跃程度明显低于往年平均水平且流行毒株型别单一,其余监测年度基本符合我国南、北方地区流感流行特征。 相似文献
6.
在中国发现普马拉型汉坦病毒 总被引:28,自引:11,他引:28
目的:确定我国是否存在普马拉(Puumala)病毒。方法:从我国东北地区棕背Bing肺标本中用RT-PCR扩增汉坦病毒S片段基因序列,对所扩增序列进行核苷酸序列测定和分析。结果:从我国东北地区棕背Bing肺标本中扩增出长度为926碱基对的cDNA片段,核苷酸序列测定证实为普马拉病毒S片段序列。与不同型别汉坦病毒代表株进行比较表明,此次发现为新的普马拉病毒株,系统发生分析结果表明,此次发现的病毒与普马拉病毒P360、K27、CG-820、CG-17株种系相近,同源性达到99%以上。结论:我国存在普马拉病毒,我国新发现的普马拉病毒核苷酸序列和俄罗斯远东地区普马拉病毒接近。 相似文献
7.
McCaustland KA Krawczynski K Ebert JW Balayan MS Andjaparidze AG Spelbring JE Cook EH Humphrey C Yarbough PO Favorov MO Carson D Bradley DW Robertson BH 《Archives of virology》2000,145(9):1909-1918
Summary. Different patterns of disease were observed among 11 chimpanzees who were inoculated intravenously with hepatitis E virus
(HEV) positive fecal specimens from four different outbreaks (Nepal 1981, Uzbekistan 1981, Pakistan 1985, and Mexico 1986).
Five chimpanzees had marginal or no liver enzyme elevations within 70 days of inoculation. Two of the chimpanzees had limited
viremia, but did not produce detectable antibody. The four remaining chimpanzees had liver enzyme elevations, viral shedding,
viremia, seroconversion to anti-HEV, and detectable HEV antigen in liver biopsy specimens. These results may reflect the range
of infection patterns that develop in humans after natural exposure to the HEV.
Received December 29, 1999/Accepted February 21, 2000 相似文献
8.
Nigel A. Cunliffe Bimal K. Das Madhumati Ramachandran Maharaj K. Bhan Roger I. Glass Jon R. Gentsch 《Virus genes》1997,15(1):39-44
We have sequenced the genes encoding the inner capsid protein VP6 and the nonstructural proteins NSP1 and NSP4 of the Indian
neonatal serotype P8[11]G9 human/bovine reassortant candidate vaccine rotavirus strain 116E. These three genes share a high
degree of sequence and deduced amino acid homology with human prototype strain Wa. Our results confirm and extend those of
previous RNA-RNA hybridization studies which suggested that these genes are of human origin, and will facilitate examination
of the host immune response to 116E induced by natural infection and vaccination.
This revised version was published online in July 2006 with corrections to the Cover Date. 相似文献
9.
目的评价麻疹IgG抗体亲和力试验对判定麻疹病例的价值。方法以中国疾病预防控制信息系统2013-2015年天津市麻疹实验室确诊病例和麻疹排除病例为研究对象。回顾性追溯保存的病例血清,开展麻疹IgG抗体亲和力试验,重新对麻疹排除病例进行归类。结果共收集到326例麻疹病例血标本,其中实验室确诊病例267例,排除病例59例,≥20岁病例占92.33%(301/326)。麻疹IgG抗体亲和力试验显示,确诊病例和排除病例中麻疹IgG高亲和力抗体的比例分别为66.95%(158/236)和91.23%(52/57),差异有统计学意义(χ2=13.33,P<0.001)。根据判定标准,15.25%(9/59)排除病例被重新判定为麻疹病例,其中8例是高亲和力抗体,有含麻疹成分疫苗(MCV)免疫史,判定为继发性免疫失败病例;1例为低亲和力抗体,有典型的麻疹临床症状,无MCV免疫史。结论麻疹IgG抗体亲和力试验能够提供有参考意义的血清学证据,可以减少麻疹急性期血清学诊断中由于IgM抗体假阴性而造成的错误排除。 相似文献
10.
肾综合征出血热疫苗后备筛选毒株在Vero细胞上的适应传代及其抗原性研究 总被引:1,自引:1,他引:1
〔目的〕将肾综合征出血热疫苗后备毒株适应于Vero细胞 ,观察病变情况 ,并对其抗原性和繁殖特性进行研究。〔方法〕将新分离的汉坦病毒ZJ2、ZJ4、ZJ7株和汉城病毒ZJ5株在Vero细胞上进行连续传代 ,采用间接免疫荧光法(IFA)、反向被动血凝试验 (RPHA) ,研究传代后毒株的病毒滴度、抗原量以及细胞的病变情况 ,同时将传代后的病毒接种敏感动物 ,观察动物的发病情况和毒株的繁殖特性。〔结果〕经过 5次连续传代 ,四株病毒在Vero细胞上均显示出良好的适应性 ,从第二代开始病毒滴度稳定在 6.0 0LgTCID5 0 ml以上 ,第五代时最高达 7.5 0LgTCID5 0 ml ,第三代毒株抗原量均已达到 1:12 8,ZJ7株抗原量最高时达 1:768,四株毒株感染Vero细胞 ,连续观察 12d不见细胞产生病变 ,第五代细胞病毒液接种敏感动物 ,9d后动物发病甚至死亡。〔结论〕四株病毒已适应于Vero细胞 ,且具有病毒滴度高、毒力强和抗原性良好的特性 ,是Vero细胞肾综合征出血热灭活疫苗良好的后备筛选毒株。 相似文献